Neoantigens are among the newest promising targets for cancer treatment. Unlike tumor-associated antigens, neoantigens are produced only by tumor cells....

Over 430 new clinical trials, 50 new therapies, and 9 new fully curated clinically significant somatic genes included in the...

Neoantigens are among the newest promising targets for cancer treatment. Unlike tumor-associated antigens, neoantigens are produced only by tumor cells....

Two expert-curated databases exclusively licensed through QIAGEN link sequence-level somatic mutation data to detailed molecular information about functional and clinical...

The Cancer Gene Census (CGC) catalogues genes with mutations causally implicated in cancer and explains how dysfunction of these genes...

Nearly two dozen new fully curated somatic genes and 387 clinical trials included in COSMIC Actionability v8 release We are...